Global Pruritus Therapeutics Market is expected to reach USD 16.38
Billion by 2025, according to a new study by Grand View Research, Inc.
Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis
and urticaria is expected to drive market growth during the forecast period.
Introduction of new products based on scientific mechanistic understanding such
as the identification of new T-cell subsets, particularly Th17, and Th22 and
the patent expiration of PROTOPIC (tacrolimus) is expected to open up new
avenues for manufacturers to capitalize on over the forecast period.
Corticosteroids were the leading product segment in 2013
owing to high efficacy exhibited by this class of drugs in treating pruritic
conditions by reducing inflammation and itching. Topical applications of
corticosteroids have been found to be extremely effective in the treatment and
maintenance therapies pertaining to pruritus.
Full Research Report on Global Pruritus Therapeutics
Market Analysis:
Further key findings from the study suggest:
- Calcineurin
inhibitor is identified as the most lucrative segment of the market on
account of high usage rate of these drugs in combination therapy for the
treatment of pruritus in patients suffering from chronic pruritus and
growing market penetration rates. Moreover, the introduction of new
products such as Pimecrolimus cream and Tacrolimus ointment is expected to
further drive this market.
- Anti-histamines
owing to its growing use as a first line treatment and presence of drugs
in pipeline with expected commercialization is also expected to grow at a
healthy rate during the forecast period.
- North
America led the overall market in terms of revenue in 2013 majorly on
account of the presence of high prevalence of diseases associated with
pruritus, introduction of new products targeting the unmet medical needs
and growing patient awareness levels.
- The
Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of
over 5.0% during the forecast period. Presence of high unmet healthcare
needs and increasing prevalence of allergic contact dermatitis and
urticaria in this region are some factors attributing to its rapid growth
rate.
- Some
key participants of the pruritus therapeutics market include Sanofi,
Pfizer, Tai Guk Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara
Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.
- Manufacturers
adhere to rigorous R&D in an attempt to develop cost effective
products and avoid barriers such as product recalls. In addition, this
strategy is implemented keeping the unmet needs in consideration. For
Instance, Creabilis has a molecule in the pipeline – CT327, which caters
to the unmet needs associated with pruritus in patients suffering from
psoriasis.
View more reports of
this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals
For the purpose of
this study, Grand View Research has segmented the Global Pruritus Therapeutics
Market on the basis of product, disease type and region:
Global Pruritus Therapeutics Product Outlook (Revenue,
USD Million, 2012 - 2025)
- Corticosteroids
- Antihistamines
- Local
Anesthetics
- Counterirritants
- Immunosuppressant
- Calcineurin
Inhibitors
- Others
Global Pruritus Therapeutics Disease Type Outlook
(Revenue, USD Million, 2012 - 2025)
- Atopic
Dermatitis
- Allergic
Contact Dermatitis
- Urticaria
- Others
Global Pruritus Therapeutics Regional Outlook (Revenue,
USD Million, 2012 - 2025)
- North
America
- U.S.
- Rest
of North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- Japan
- Rest
of Asia Pacific
- RoW
View Press Release of this research report by Grand View
Research: http://www.grandviewresearch.com/press-release/global-pruritus-therapeutics-market
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment